Successful Treatment of Chronic Hepatitis C Infection with Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report

Transplantation Proceedings

Volumn 47, Issue 7, 2015, Pages 2295-2297

  Trakroo, S ^a   Qureshi, K ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; CREATININE; CYCLOSPORIN; INTERFERON; LIVER ENZYME; MYCOPHENOLATE MOFETIL; PREDNISONE; SIMEPREVIR; SOFOSBUVIR; TACROLIMUS;

ADULT; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ANTIVIRAL THERAPY; BODY MASS; CASE REPORT; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS C; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; DISEASE SURVEILLANCE; ECHOCARDIOGRAPHY; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH CARE QUALITY; HEART EJECTION FRACTION; HEART GRAFT; HEART MUSCLE BIOPSY; HEART STRESS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER BIOPSY; MALE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; VIRAL LOAD TESTING; VIRUS LOAD; BIOPSY; HEART TRANSPLANTATION; HEPATITIS C, CHRONIC;

ADULT; ANTIVIRAL AGENTS; BIOPSY; HEART TRANSPLANTATION; HEPATITIS C, CHRONIC; HUMANS; MALE; SIMEPREVIR; SOFOSBUVIR;

EID: 84940986750     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2015.06.003     Document Type: Conference Paper

References (25)

1. O. Cano, L. Almenar, L. Martínez-Dolz, and et al. Course of patients with chronic hepatitis C virus infection undergoing heart transplantation Transplant Proc 39 2007 2353
2. M. Castella, G. Tenderich, M.M. Koerner, and et al. Outcome of heart transplantation in patients previously infected with hepatitis C virus J Heart Lung Transplant 20 2001 595
3. S. Fagiuoli, F. Minniti, S. Pevere, and et al. HBV and HCV infections in heart transplant recipients J Heart Lung Transplant 20 2001 718
4. T.L. Fong, L. Hou, I.V. Hutchinson, and et al. Impact of hepatitis C infection on outcomes after heart transplantation Transplantation 88 2009 1137
5. I. Lee, R. Localio, C.M. Brensinger, and et al. Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity J Heart Lung Transplant 30 2011 1266 1274
6. K.A. Bodziak, and D.E. Hricik New-onset diabetes mellitus after solid organ transplantation Transpl Int 22 2009 519
7. P. Burra, A. Buda, U. Livi, and et al. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? Eur J Gastroenterol Hepatol 18 2006 1065
8. C.J. Hoffmann, A.K. Subramanian, A.M. Cameron, and et al. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation Transplantation 86 2008 784
9. F. Fabrizi, S. Bunnapradist, and P. Martin Treatment of hepatitis C in potential kidney and heart transplant patients Clin Liver Dis 9 2005 487
10. E. Durante-Mangonia, E. Ragonea, D. Pinto, and et al. Outcome of treatment with pegylated interferon and ribavirin in heart transplant recipients with chronic hepatitis C Transplant Proc 43 2011 299 303
11. K.H. Shu, J.L. Lan, M.J. Wu, and et al. Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients Transplantation 77 12 2004 1894 1896
12. M. Durlik, Z. Gaciong, Z. Rancewicz, and et al. Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha Transplant Proc 27 1 1995 958 959
13. B.Y. Wang, H.H. Chang, I.M. Chen, and et al. Peginterferon alpha-2b and acute allograft failure in a heart transplant recipient Ann Thorac Surg 89 2010 1645 1647
14. J. Levitsky, K. Doucette AST Infectious diseases community of practice Viral hepatitis in solid organ transplant recipients Am J Transplant 9 suppl 4 2009 S116 S130
15. M.W. Fried, M.L. Shiffman, K.R. Reddy, and et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
16. L. Rostaing, J. Izopet, E. Baron, and et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients Transplantation 59 10 1995 1426 1431
17. M. Charlton, E. Gane, M.P. Manns, and et al. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation Gastroenterology 148 2015 108 117
18. R.S. Brown, K.R.J. Reddy, J.G. O'Leary, and et al. Safety and efficacy of new DAA-based therapy for hepatitis C post-transplant: interval results from the HCV-TARGET longitudinal, observational study Hepatology 60 2014 1269A
19. Thomas AM. SVR durability: HCV patients treated with IFN-free DAA regimens. Poster presented at: 2015 Conference on Retroviruses and Opportunistic Infections (CROI), February 23-26, 2015; Seattle, abstract 653.
20. US Department of Health and Human Services. Scientific registry of transplant recipients. Available at: http://srtr.transplant.hrsa.gov/annual-reports/2012/Default.aspx. Accessed February 23, 2015.
21. K.D. Lake, C.I. Smith, S.K.M. LaForest, and et al. Policies regarding the transplantation of hepatitis C positive candidates and donor organs J Heart Lung Transplant 16 1997 917 921
22. J.T. Wells, M.R. Lucey, and A. Said Hepatitis C in transplant recipients of solid organs, other than liver Clin Liver Dis 10 2006 901
23. S. Fagiuoli, S. Pevere, F. Minniti, and et al. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients Transplantation 75 2003 982 986
24. G.S. Gudmundsson, K. Malinowska, J.A. Robinson, and et al. Five-year follow-up of hepatitis C-naïve heart transplant recipients who received hepatitis C-positive donor hearts Transplant Proc 35 2003 1536
25. American Association of the Study of Liver Diseases and Infectious Diseases Society of America Recommendations for testing, managing, and treating hepatitis C Available at: www.hcvguidelines.org/full-report-view 2014 Accessed February 8, 2015